Akili Inc (AKLI)
NASDAQ (CM) NASDAQ (CM) Primary Summary
AKLI Chart
People also search for
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, CALT on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Akili, Inc. (NASDAQ:AKLI)'s sale to Virtual Therapeutics for $0.4340 per share of common stock in cash. If you are an Akili shareholder, click here to learn more about your rights and options.
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger and Expiring Tender Offer - AKLI and CALT
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are now investigating: Akili, Inc. (NASDAQ: AKLI ), relating to a tender offer from Vital Therapeutics Corporation.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKLI, SGE on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Akili, Inc. (NASDAQ:AKLI)'s sale to Virtual Therapeutics for $0.4340 per share of common stock in cash. If you are an Akili shareholder, click here to learn more about your rights and options.
Akili Inc (AKLI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Akili Inc ever had a stock split?
Akili Inc Profile
| Insurance Industry | Financials Sector | Matthew Franklin CEO | NASDAQ (CM) Exchange | 00974B107 CUSIP |
| US Country | 68 Employees | - Last Dividend | - Last Split | 19 Aug 2022 IPO Date |
Overview
Akili, Inc. stands out as a pioneering digital medicine company dedicated to developing innovative cognitive treatments via groundbreaking technologies. Founded in 2011 and based in Boston, Massachusetts, Akili is at the forefront of merging medical science with cutting-edge technology to address cognitive dysfunctions. The company aims to revolutionize the healthcare sector by providing digital solutions that cater to a wide range of neurological and psychiatric conditions. Through their work, Akili is not only challenging traditional therapeutic models but also paving the way for a new era of digital treatment options that are accessible, efficient, and effective.
Products and Services
Akili, Inc. offers a diverse portfolio of products and services designed to tackle various cognitive dysfunctions. Each product utilizes unique digital platforms and mechanisms to target specific areas of brain function, promising a new dimension of treatment for patients and healthcare providers alike.
- EndeavorRx - A groundbreaking computer-based testing platform for cognitive dysfunction, EndeavorRx is specifically designed to address several neurology and psychiatry indications. This includes attention-deficit hyperactivity disorder (ADHD), depressive disorder, autism spectrum disorder (ASD), multiple sclerosis (MS), and other neuroinflammatory diseases. By employing engaging and therapeutic digital experiences, EndeavorRx works to improve cognitive functions in a user-friendly manner.
- Selective Stimulus Management Engine - This innovative mechanism activates the fronto-parietal cortex area of the brain, which is crucial for cognitive functions such as attention, decision-making, and problem-solving. The selective stimulus management engine is a testament to Akili’s commitment to leveraging technology for enhancing brain performance and overall mental health.
- Body Brain Trainer - This product is designed to improve cognitive abilities such as attention, impulsivity, working memory, and goal management. The Body Brain Trainer integrates physical and cognitive exercises, demonstrating Akili’s holistic approach to cognitive well-being. By focusing on both the mind and body, they provide a comprehensive training tool that targets multiple aspects of cognitive health.
- Spatial Navigation Engine - Aimed at enhancing spatial navigation, memory, planning, and organization skills, the Spatial Navigation Engine addresses key components of cognitive health that are essential for daily functioning. This product underscores the importance of cognitive flexibility and spatial awareness, offering users a novel pathway to improving their cognitive landscape.
